...
首页> 外文期刊>Journal of Clinical Microbiology >Comparison of PCR, Nested PCR, and Random Amplified Polymorphic DNA PCR for Detection and Typing of Ureaplasma urealyticum in Specimens from Pregnant Women
【24h】

Comparison of PCR, Nested PCR, and Random Amplified Polymorphic DNA PCR for Detection and Typing of Ureaplasma urealyticum in Specimens from Pregnant Women

机译:PCR,巢式PCR和随机扩增多态性DNA PCR在孕妇标本中解脲脲原体检测和分型的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A PCR assay, using three primer pairs, was developed for the detection of Ureaplasma urealyticum, parvo biovar,mba types 1, 3, and 6, in cultured clinical specimens. The primer pairs were designed by using the polymorphic base positions within a 310- to 311-bp fragment of the 5′ end and upstream control region of the mba gene. The specificity of the assay was confirmed with reference serovars 1, 3, 6, and 14 and by the amplified-fragment sizes (81 bp for mba 1, 262 bp formba 3, and 193 bp for mba 6). A more sensitive nested PCR was also developed. This involved a first-step PCR, using the primers UMS-125 and UMA226, followed by the nestedmba-type PCR described above. This nested PCR enabled the detection and typing of small numbers of U. urealyticumcells, including mixtures, directly in original clinical specimens. By using random amplified polymorphic DNA (RAPD) PCR with seven arbitrary primers, we were also able to differentiate the two biovars of U. urealyticum and to identify 13 RAPD-PCR subtypes. By applying these subtyping techniques to clinical samples collected from pregnant women, we established that (i) U. urealyticum is often a persistent colonizer of the lower genital tract from early midtrimester until the third trimester of pregnancy, (ii) mba type 6 was isolated significantly more often (P = 0.048) from women who delivered preterm than from women who delivered at term, (iii) no particular ureaplasma subtype(s) was associated with placental infections and/or adverse pregnancy outcomes, and (iv) the ureaplasma subtypes most frequently isolated from women were the same subtypes most often isolated from infected placentas.
机译:开发了一种使用三对引物的PCR检测试剂盒,用于检测培养的临床标本中的解脲脲原体,细小生物变种, mba 1、3和6型。通过使用 mba 基因5'末端的310至311bp片段内的多态性碱基位置设计引物对。用参考血清1、3、6和14以及扩增片段大小( mba 为81 bp, mba 为262 bp)证实了测定的特异性。 3, mba 6为193 bp)。还开发了更灵敏的巢式PCR。这涉及第一步,使用引物UMS-125和UMA226进行PCR,然后进行上述的嵌套 mba 型PCR。这种嵌套式PCR可以检测和键入少量 U。直接在原始临床标本中的解脲酶细胞(包括混合物)。通过使用带有七个任意引物的随机扩增多态性DNA(RAPD)PCR,我们还能够区分 U的两个生物变种。解脲酶并鉴定出13种RAPD-PCR亚型。通过将这些分型技术应用于从孕妇收集的临床样本,我们确定了(i)U。解脲酶通常是从中期中期至妊娠晚期一直是下生殖道的永久定居者,(ii)6型 mba 的分离率更高( P = 0.048)早产的妇女比足月分娩的妇女(iii)没有特定的脲原体亚型与胎盘感染和/或不良妊娠结局有关,以及(iv)最常见的脲原体亚型来自女性的是相同的亚型,最常从感染的胎盘中分离出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号